CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Chromoendoscopy and Virtual Chromoendoscopy as an Adjunct to Colonoscopy

This policy governs coverage and reimbursement for chromoendoscopy and virtual chromoendoscopy when performed with diagnostic or surveillance colonoscopy for BlueCHiP for Medicare and Commercial products; it affects providers performing colonoscopy for BCBSRI members.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyChromoendoscopy and Virtual Chromoendoscopy as an Adjunct to Colonoscopy

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionDo not bill separately for chromoendoscopy or virtual chromoendoscopy when performed adjunctively with diagnostic or surveillance colonoscopy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

incidentalConsidered incidental

no specific CPTCPT availability

44799If reported

insufficientEvidence - average risk

higher detectionEvidence - IBD/high-risk

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria and Evidence Summary

Coverage summary and evidence

Covered, not covered, and evidence notes for BlueCHiP for Medicare and Commercial Products

Coverage stance: Chromoendoscopy and virtual chromoendoscopy performed as an adjunct to diagnostic or surveillance colonoscopy are considered incidental to the colonoscopy and are not separately reimbursed for BlueCHiP for Medicare and Commercial products.

See coding module: there is no specific CPT code; if reported use unlisted CPT 44799.

Evidence — average risk screening: For average-risk colorectal cancer screening, randomized controlled trials and meta-analyses have not demonstrated that chromoendoscopy or virtual chromoendoscopy detects more clinically meaningful lesions or improves health outcomes (e.g., CRC incidence or mortality). The evidence is insufficient to determine effects on health outcomes.

Based on RCTs and systematic reviews comparing high-definition chromoendoscopy/virtual chromoendoscopy with standard white-light colonoscopy.

Evidence — increased risk and IBD surveillance: Some RCTs, back-to-back studies, and systematic reviews report higher adenoma or dysplasia detection with chromoendoscopy (including in high‑risk patients and in inflammatory bowel disease surveillance), but it is unclear whether the additional lesions detected are clinically important or will translate to improved health outcomes; comparisons may be confounded by suboptimal standard colonoscopy in control groups.

Findings include higher adenoma detection in high‑risk groups and higher dysplasia yield in IBD meta‑analyses, but overall evidence remains insufficient for health outcome benefit.

Chromoendoscopy and virtual chromoendoscopy performed adjunctively with a diagnostic or surveillance colonoscopy are considered incidental to the colonoscopic procedure. As a result, these techniques are not separately reimbursed when provided as part of the colonoscopy for BlueCHiP for Medicare and Commercial products.

Coding and Billing Guidance

Reported if chromoendoscopy is codedCPT

44799

Unlisted procedure, intestine

Provider Actions and Billing Rules

Prior Authorization

Not applicable

Note

Benefit / Eligibility Verification

Benefits may vary between groups/contracts. Please refer to the appropriate Benefit Booklet, Evidence of Coverage, or Subscriber Agreement for applicable surgery benefit/coverage.

Denial Risk

Separate Reimbursement Denied

BlueCHiP for Medicare and Commercial Products: Chromoendoscopy and virtual chromoendoscopy as an adjunct to diagnostic or surveillance colonoscopy is considered incidental to the colonoscopy and therefore is not separately reimbursed.

Background

Chromoendoscopy refers to techniques used during colonoscopy to enhance visualization of mucosal abnormalities — either by applying dyes or using electronic image-enhancement methods (virtual chromoendoscopy). These adjunctive approaches are intended to improve detection of flat lesions or better characterize mucosal findings, but when performed as part of a diagnostic or surveillance colonoscopy they are treated as part of the colonoscopy service and not billed separately.

Definitions

Chromoendoscopy / Chromocolonoscopy

DefinitionApplication of topical dyes or stains during endoscopy to enhance tissue differentiation or characterization; when used with colonoscopy the intent is to increase sensitivity by facilitating identification of mucosal abnormalities.

ModalitiesPan‑colonic (spraying dye across the entire colon) vs targeted (spraying dye onto specific suspicious areas); dyes/stains are applied via a spray catheter through the endoscope working channel.

PurposeEnhance visualization of mucosal surface morphology to help detect flat or depressed lesions and improve lesion characterization during colonoscopy.

Contrast with tattooingStains used in chromoendoscopy are transient and intended for visualization enhancement, not permanent marking (tattooing).

Technique variabilityProcedure variables (dye concentration and amount sprayed) are not standardized, which may affect interpretation of staining patterns.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyChromoendoscopy and Virtual Chromoendoscopy as an Adjunct to Colonoscopy

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionDo not bill separately for chromoendoscopy or virtual chromoendoscopy when performed adjunctively with diagnostic or surveillance colonoscopy.

SourceLink

On This Page

Note

Provider Notice

This medical policy is made available to you for informational purposes only. It is not a guarantee of payment or a substitute for your medical judgment. Benefits and eligibility are determined by the member's subscriber agreement or member certificate and/or the employer agreement, and those documents will supersede the provisions of this medical policy. For member-specific benefits, call the provider call center. If services are determined to be not medically necessary or are non-covered benefits, providers may not charge the member unless the member has been informed and agreed in writing to continue at their own expense. BCBSRI reserves the right to review and revise this policy at any time.

Virtual chromoendoscopy (electronic)

DefinitionImaging enhancements using endoscopy system postprocessing algorithms to simulate the color/light effects of dye spraying without applying topical dyes (also called electronic chromoendoscopy).

ExamplesFujinon FICE (Fujifilm) and i‑SCAN (Pentax) — digital image enhancement technologies cleared by FDA as adjuncts to white‑light endoscopy.

How it worksPostprocessing computer algorithms modify reflected light wavelengths or digitally enhance images in real time to mimic dye‑induced contrast.

Intended useIntended as an adjunct to white‑light endoscopy to assist visualization but not to replace histopathologic sampling for diagnosis.